-
IMPACT OF TAFAMIDIS USE IN COLOMBIAN PATIENTS DIAGNOSED WITH ATTR-CM ON HEALTH-RELATED QUALITY OF LIFE DURING TWO YEARS OF FOLLOW-UP: REAL WORLD STUDY IN COLOMBIA
Mar 18, 2026, 21:38 PM -
TRANSFORMING VACCINE AVAILABILITY THROUGH REAL-TIME LAST-MILE VISIBILITY: A SYSTEMS APPROACH TO STRENGTHENING STOCK DATA IN NIGERIAN PHC FACILITIES
Mar 18, 2026, 21:38 PM -
REAL-WORLD DISEASE ACTIVITY AND TREATMENT RESPONSIVENESS AMONG ADULTS WITH RHEUMATOID ARTHRITIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ACUPUNCTURE TREATMENT COMPARED TO PLACEBO IN VETERANS WITH COMBAT-RELATED POSTTRAUMATIC STRESS DISORDER (PTSD)
Mar 18, 2026, 21:38 PM -
MODELING THE IMPACT OF TRANSCAROTID ARTERY REVASCULARIZATION VERSUS CAROTID ENDARTERECTOMY ON OPERATING ROOM EFFICIENCY AND THROUGHPUT
Mar 18, 2026, 21:38 PM -
DO 340B CHILD SITES IMPROVE ACCESS TO CANCER CARE FOR LOW INCOME PATIENTS?
Mar 18, 2026, 21:38 PM -
MODELING THE COST-EFFECTIVENESS OF RISK-STRATIFIED SCREENING FOR ESOPHAGEAL CANCER IN CHINA
Mar 18, 2026, 21:38 PM -
EXPLANATION AND ELABORATION OF THE DEEM-Q CHECKLIST: GUIDANCE FOR ASSESSING THE METHODOLOGICAL QUALITY OF ECONOMIC EVALUATIONS OF MEDICAL DEVICES
Mar 18, 2026, 21:38 PM -
THE ILLUSION OF COMPLIANCE: WHY ECOA-ONLY MONITORING FALLS SHORT IN DETECTING AND ADDRESSING DATA GAPS
Mar 18, 2026, 21:38 PM -
MEASURING MEANINGFUL ENGAGEMENT: A PATIENT ENGAGEMENT METRICS FRAMEWORK FOR PATIENT-GENERATED PRIMARY DATA QUALITY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LEBRIKIZUMAB VERSUS NEMOLIZUMAB FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE US: A 10-YEAR ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
HOSPITALS' TRANSITIONS TO INCREASED OUTPATIENT CARE: IS THERE AN IMPACT ON HOSPITAL-WIDE 30-DAY READMISSIONS? AN ANALYSIS OF DATA FROM THE CENTERS FOR MEDICARE AND MEDICAID SERVICES, 2014-2023
Mar 18, 2026, 21:38 PM -
UNMET MEDICAL CARE NEEDS AMONG PATIENTS WITH DEMENTIA AND THEIR FAMILY MEMBERS: A HOUSEHOLD-LEVEL ANALYSIS OF MEPS
Mar 18, 2026, 21:38 PM -
ADOPTION AS A MISSING LINK IN HEOR: EVIDENCE MAPPING OF HEALTHCARE INNOVATION UPTAKE
Mar 18, 2026, 21:38 PM -
CHARACTERIZING ONCOLOGY PATIENT JOURNEYS AND HEALTH STATE TRANSITIONS USING A DATA-DRIVEN MARKOV TRANSITION MATRIX IN LARGE-SCALE ELECTRONIC HEALTH RECORDS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF TRASTUZUMAB REZETECAN VERSUS TRASTUZUMAB DERUXTECAN FOR THE SUBSEQUENT-LINE TREATMENT OF ADVANCED HER2-MUTANT NON-SMALL-CELL LUNG CANCER: APPLICATION OF A MATCHING-ADJUSTED INDIRECT COMPARISON
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF VELIGROTUG VERSUS TEPROTUMUMAB FOR MODERATE-TO-SEVERE THYROID EYE DISEASE IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
IMPACT OF FCGR3A V158F POLYMORPHISM ON RITUXIMAB EFFICACY: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
MENTAL HEALTH, SUICIDALITY, AND UNDERRECOGNIZED PSYCHOLOGICAL BURDEN IN PREMANIFEST HUNTINGTON’S DISEASE: INSIGHTS FROM THE PRE-HDBOI STUDY
Mar 18, 2026, 21:38 PM -
CONCENTRATION OF 340B PROGRAM EXPANSION AMONG HOSPITALS OF VARYING SIZE: A RETROSPECTIVE ANALYSIS, 2017-2023
Mar 18, 2026, 21:38 PM
